A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors
Shanghai Henlius Biotech
Shanghai Henlius Biotech
Radiopharm Theranostics, Ltd
Emory University
UNC Lineberger Comprehensive Cancer Center
Poitiers University Hospital
Karolinska University Hospital
Wondercel Biotech (ShenZhen)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Var2 Pharmaceuticals
TCRCure Biopharma Ltd.
Sichuan University
Peking Union Medical College Hospital
Second Affiliated Hospital of Guangzhou Medical University
Second Affiliated Hospital of Guangzhou Medical University
Henan Cancer Hospital
Second Affiliated Hospital, School of Medicine, Zhejiang University
Sichuan University
State University of New York - Upstate Medical University